Searched for
PHARMACEUTICAL COMPLIANCE
Maharashtra FDA trains guns on overpriced drugsMaharashtra FDA plans to approach the NPPA regarding exorbitant drug prices. The agency is examining data and will take action against unet...- India takes action against 90% of inspected high-risk pharmaceutical facilities, regulator saysAmid increasing global concerns over Indian pharmaceuticals, India's drug regulator is rigorously addressing high-risk manufacturing sites....
- FSSAI suspends licence of Dior Pharmaceuticals for violations at nutraceutical plantThe FSSAI has suspended Dior Pharmaceuticals' license due to serious violations. The nutraceutical factory operated with severely deficient...
- Gujarat industry seeks easier access to incentives, lower cost of doing businessIndustry stakeholders say the opportunity for them lies in strengthening the link between its large industrial base and MSMEs while reducin...
- Trump's tariffs just went from 12.5% to 10%: Why did India get a breather and what it means?The United States has reduced tariffs on most Indian exports to ten percent. This change follows India's recent actions against forced labo...
- Cabinet approves Rs 3,030 crore Bhavya Rasayan Scheme for three chemical parksWith a financial commitment of Rs 3,030 crore, the Union Cabinet has approved the Bhavya Rasayan Scheme. This forward-thinking initiative w...
- Trump’s 10% tariff blow that could work in India’s favourThe US Section 301 tariff has escalated cost challenges for Indian exporters, but it simultaneously provides a unique advantage. Competing ...
- Recurring West Asia tensions force MSME exporters to prioritise resilience over cost savingsIndustry officials say recurring geopolitical disruptions, rising freight costs, and shipping uncertainty are making supply chain resilienc...
- Indian pharma firms may yet survive Trump's 200% tariff bombshellDonald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...
- Hikal commissions cGMP pilot plant in Pune to strengthen pharmaceutical developmentHikal has commissioned an enhanced cGMP pilot plant at its Pune campus to strengthen its integrated capabilities for pharmaceutical develop...
- The Project-Driven OrganizationIn an era when adaptability and innovation are paramount, organizations are recognizing the pivotal role of projects in driving success. In...
- AI is reshaping hiring, making evidence-based verification more critical: Millow's Karan BhattyAI is revolutionising Indian hiring by enhancing candidate preparation and employer verification processes. Companies now prioritise eviden...
- India-UK FTA comes into effect today, unlocking duty-free access for Indian exportsIndia and the UK have enacted a free trade agreement, opening significant export opportunities. This pact offers duty-free access on ninety...
- Schmersal Inaugurates Global Competence Center (SGCC) at AP4 Tech Park, PuneThe German safety technology group has opened its Global Competence Center and opened a new Product Experience Center at Amar Builders & Pr...
- India-UK FTA offers big opportunity, but implementation gaps remain: IndustryBusinesses welcome the pact but seek clarity on implementation details and regulations. Technical standards and rules of origin require fur...
- Tripura gets Rs 1.21 lakh crore investment pledges at Agartala business conclaveTripura secured 342 MoUs worth Rs 1.21 lakh crore at a business conclave. The state aims to become a manufacturing, logistics, and services...
- Maharashtra FDA bars sale of two Cadila drugs over branding concernsMaharashtra FDA has seized Cadila Pharmaceuticals drug stock worth Rs 2.45 crore. The action was taken due to similar branding on different...
- India-UK FTA: Pharma industry flags regulatory priorities ahead of July 15 rolloutIndustry stakeholders expect stronger trade, investment, and research partnerships but say implementation clarity will determine the pact’s...
- Dr Reddy’s pauses weight loss drug on quality fearsDr Reddy's Laboratories will halt semaglutide injection supplies until at least October. Unspecified impurities were identified during the ...
- Govt to plug regulatory gaps in drug dealsAuthorities discovered drugmakers hid licence cancellations to obtain supply orders. The government now mandates states display this inform...
Load More
